2021年8月7日Cancer CellMurayama A, Ueda M, Shrestha S, Tanimoto T, Ozaki AJapan’s conditional early approval program for innovative cancer drugs: Comparison of the regulatory processes with the US FDA and the EMA2021/8/5
Murayama A, Ueda M, Shrestha S, Tanimoto T, Ozaki AJapan’s conditional early approval program for innovative cancer drugs: Comparison of the regulatory processes with the US FDA and the EMA2021/8/5
